Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
102
datasets available to search
ShareScore release 0.9.0
Dataset results
102 results for “Differentiated thyroid cancer;”
A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy
ClinicalTrials.gov study NCT02702388. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT00984282. IPD Sharing: Not stated. Countries: 18. Publications: 5.
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR)
ClinicalTrials.gov study NCT03690388. IPD Sharing: NO. Countries: 25. Publications: 2.
Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT01723202. IPD Sharing: NO. Countries: 1. Publications: 3.
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT03914300. IPD Sharing: YES. Countries: 1. Publications: 1.
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
ClinicalTrials.gov study NCT02973997. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT02244463. IPD Sharing: NO. Countries: 1. Publications: 1.
Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT01843062. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT00668811. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
ClinicalTrials.gov study NCT01321554. IPD Sharing: Not stated. Countries: 23. Publications: 7.
Supplementary tables from: Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood
Open the record for dataset details and reuse information.
PET Evaluation of Recurrent Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT01641679. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
ClinicalTrials.gov study NCT02303444. IPD Sharing: Not stated. Countries: 19. Publications: 4.
A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
ClinicalTrials.gov study NCT02966093. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT02390934. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawa
ClinicalTrials.gov study NCT04971473. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Apatinib in Patients With Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT02731352. IPD Sharing: NO. Countries: 1. Publications: 3.
Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT00061906. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT03602495. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
ClinicalTrials.gov study NCT00415233. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.